Pretreatment triglycerides‐to‐high density lipoprotein cholesterol ratio in postmenopausal women with endometrial cancer

Raised triglycerides (TG) and reduced high density lipoprotein cholesterol (HDL‐c) are components of metabolic syndrome. Both high TG and metabolic syndrome have been reported to be risk factors of endometrial cancer. Therefore, triglycerides‐to‐high density lipoprotein cholesterol ratio (TG/HDL‐c ratio) may be a useful biological indicator in managing endometrial cancer. We aimed to explore the association between pretreatment TG/HDL‐c ratio and endometrial cancer in postmenopausal women, and to evaluate its potential role in the disease. Pretreatment serum lipid profile and TG/HDL‐c ratio were retrospectively analyzed for 167 postmenopausal women with endometrial cancer and 464 matched noncancer controls. Compared with controls, pretreatment TG/HDL‐c ratio in endometrial cancer patients significantly elevated regardless of whether patients had diabetes or overweight/obesity (P